Citation Impact
Citing Papers
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
2000 Standout
Conserved T cell receptor α-chain induces insulin autoantibodies
2008
Treatment With the Radiolabeled Somatostatin Analog [ 177 Lu-DOTA 0 ,Tyr 3 ]Octreotate: Toxicity, Efficacy, and Survival
2008
Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer
2014 StandoutNobel
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
2000 Standout
Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma.
1999
Guidelines for the welfare and use of animals in cancer research
2010 Standout
Non-invasive 19F MR spectroscopy of 5-fluorocytosine to 5-fluorouracil conversion by recombinant Salmonella in tumours
2003
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres
2010 Standout
PET in oncology: Will it replace the other modalities?
1997
Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers.
1998
ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology
2006 Standout
Molecular imaging in drug development
2008 Standout
Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis
2011
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer
2008 Standout
Enteroviruses in the pathogenesis of type 1 diabetes
2010
5-fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors
1998
Monitoring response to therapy in cancer using [ 18 F]-2-fluoro-2-deoxy- d -glucose and positron emission tomography: an overview of different analytical methods
2000
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Minimally Invasive Pharmacokinetic and Pharmacodynamic Technologies in Hypothesis-Testing Clinical Trials of Innovative Therapies
2006
Monitoring chemotherapy and radiotherapy of solid tumors
2006
[18F]FDG PET monitoring of tumour response to chemotherapy: does [18F]FDG uptake correlate with the viable tumour cell fraction?
2003
Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer.
1996
Cushing's syndrome
2015 Standout
An Early Phase II Study of Oral S-1, a Newly Developed 5-Fluorouracil Derivative for Advanced and Recurrent Gastrointestinal Cancers
1999
Esophageal Cancer
2003 Standout
A prospective analysis of 949 long-term central venous access catheters for ambulatory chemotherapy in patients with gastrointestinal malignancy
1997
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
The Matrix Metalloproteinases and Their Inhibitors in the Treatment of Pancreatic Cancer
1999
5-Fluorouracil plasma levels and biodegradation of subcutaneously injected drug-loaded microspheres prepared by spray-drying poly(d,l-lactide) and poly(d,l-lactide-co-glycolide) polymers
2007
Engineering the perfect (bacterial) cancer therapy
2010 Standout
Mature results from three large controlled studies with raltitrexed ('Tomudex')
1998
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
2005 Standout
Targeting the phosphoinositide 3-kinase pathway in cancer
2009 Standout
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
2000 Standout
Testicular germ-cell tumours in a broader perspective
2005 Standout
Chemotherapy and the war on cancer
2005 Standout
Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]‐2‐fluro‐2‐deoxy‐d ‐glucose positron emission tomography
2008
Clinical role of positron emission tomography in oncology
2001
Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by 18F-FDG-PET is associated with the KRAS mutation status and prognosis
2018 StandoutNobel
Type 1 diabetes
2013 Standout
Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging The Visual Response Score and the Change in Total Lesion Glycolysis
1999
Update on the treatment of neuroendocrine tumors
2003
Analysis of anticancer drugs: A review
2011 Standout
Clinical studies with matrix metalloproteinase inhibitors
1999
Gastric Small Cell Carcinoma Successfully Treated by Surgery and Postoperative Chemotherapy Consisting of Cisplatin and S-1: Report of a Case
2007 StandoutNobel
Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [18F]FDG PET
2002
Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations
1999
Insulitis in human type 1 diabetes
2011
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
2000 Standout
Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?
1998
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer.
1998
A review of analytical methods for the determination of 5-fluorouracil in biological matrices
2010
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
Colorectal cancer chemotherapy
2003
Imaging proliferation in vivo with [F-18]FLT and positron emission tomography
1998
New drugs in the treatment of colorectal carcinoma
1998
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
2010 Standout
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Intrinsic and Acquired Resistance to Methotrexate in Acute Leukemia
1996
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
2008 Standout
Final results of a randomised trial comparing ‘Tomudex’® (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer
1996
Chiral separation of raltitrexed by cyclodextrin-modified micellar electrokinetic chromatography
2008
Integrating cell-signalling pathways with NF-κB and IKK function
2006 Standout
Folate status and the safety profile of antifolates
2002
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002 StandoutNobel
Polymorphisms in melanoma differentiation‐associated gene 5 link protein function to clearance of hepatitis C virus
2014 StandoutNobel
Network for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetes
2012
Whole Body 18FDG-PET and the Response of Esophageal Cancer to Induction Therapy: Results of a Prospective Trial
2003
Revised Response Criteria for Malignant Lymphoma
2007 Standout
Positron Emission Tomography Using [18F]-Fluorodeoxy-d -Glucose to Predict the Pathologic Response of Breast Cancer to Primary Chemotherapy
2000
Positron Emission Tomography As an Imaging Biomarker
2006
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
2004 Standout
Therapeutic Alternatives in Metastatic Neuroendocrine Tumors
1998
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
2011 Standout
Positron-Emission Tomography and Assessment of Cancer Therapy
2006
Multitargeted Antifolate LY231514 as First-Line Chemotherapy for Patients With Advanced Non–Small-Cell Lung Cancer: A Phase II Study
1999
A pilot study of interferon alpha-2a, fluorouracil, and leucovorin given with granulocyte-macrophage colony stimulating factor in advanced gastrointestinal adenocarcinoma.
1999
Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors
2005
Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy
1999
Prediction of Response to Preoperative Chemotherapy in Gastric Carcinoma by Metabolic Imaging: Results of a Prospective Trial
2003
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
2017 Standout
Synthesis of Quinazolin-4(3H)-ones via Amidine N-Arylation
2013
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions
2016 Standout
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
2005
Trends in the Aggressiveness of Cancer Care Near the End of Life
2004 Standout
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Putting the Rap on Akt
2004
Update in Type 1 Diabetes
2007
Prediction of Response to Preoperative Chemotherapy in Adenocarcinomas of the Esophagogastric Junction by Metabolic Imaging
2001
Dynamic imaging of transient metabolic processes by small-animal PET for the evaluation of photosensitizers in photodynamic therapy of cancer.
2006
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
2004 Standout
Pretreatment of colon carcinoma cells with Tomudex enhances 5-fluorouracil cytotoxicity.
1998
Works of A Iveson being referenced
Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil.
1996
Phase II study of continuous infusion fluorouracil and interferon alfa-2b in the palliation of malignant neuroendocrine tumors.
1995
Measurement of plasma 5-fluorouracil by high-performance liquid chromatography with comparison of results to tissue drug levels observed using in vivo 19F magnetic resonance spectroscopy in patients on a protracted venous infusion with or without interferon-α
1996
Royal Marsden phase III trial of fluorouracil with or without interferon alfa-2b in advanced colorectal cancer.
1995
ZD1694: A novel thymidylate synthase inhibitor with substantial activity in the treatment of patients with advanced colorectal cancer. Tomudex Colorectal Study Group.
1996
The Combination of Raltitrexed (Tomudex) and Mitomycin-C in the Treatment of Advanced Colorectal Cancer — A Phase II Study
2006
Initial Results of Screening of Nondiabetic Organ Donors for Expression of Islet Autoantibodies
2006